This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rodriguez, F.
Right arrow Articles by Whitton, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodriguez, F.
Right arrow Articles by Whitton, J. L.

 Previous Article  |  Next Article 

J Virol, June 1998, p. 5174-5181, Vol. 72, No. 6
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

DNA Immunization with Minigenes: Low Frequency of Memory Cytotoxic T Lymphocytes and Inefficient Antiviral Protection Are Rectified by Ubiquitinationdagger

Fernando Rodriguez,1 Ling Ling An,1 Stephanie Harkins,1 Jie Zhang,1 Masayuki Yokoyama,2 Georg Widera,3 James T. Fuller,3 Carrie Kincaid,1 Iain L. Campbell,1 and J. Lindsay Whitton1,*

Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California 920371; PowderJect Vaccines Inc., Madison, Wisconsin 537113; and Institute of Biomedical Engineering, Tokyo Women's Medical College, Shinjuku-ku, Tokyo 162, Japan2

Received 29 December 1997/Accepted 17 March 1998

Our previous studies have shown that isolated cytotoxic T lymphocyte (CTL), B-cell, and T-helper epitopes, for which we coined the term minigenes, can be effective vaccines; when expressed from recombinant vaccinia viruses, these short immunogenic sequences confer protection against a variety of viruses and bacteria. In addition, we have previously demonstrated the utility of DNA immunization using plasmids encoding full-length viral proteins. Here we combine the two approaches and evaluate the effectiveness of minigenes in DNA immunization. We find that DNA immunization with isolated minigenes primes virus-specific memory CTL responses which, 4 days following virus challenge, appear similar in magnitude to those induced by vaccines known to be protective. Surprisingly, this vigorous CTL response fails to confer protection against a normally lethal virus challenge, although the CTL appear fully functional because, along with their high lytic activity, they are similar in affinity and cytokine secretion to CTL induced by virus infection. However this DNA immunization with isolated minigenes results in a low CTL precursor frequency; only 1 in ~40,000 T cells is epitope specific. In contrast, a plasmid encoding the same minigene sequences covalently attached to the cellular protein ubiquitin induces protective immunity and a sixfold-higher frequency of CTL precursors. Thus, we show that the most commonly employed criterion to evaluate CTL responses---the presence of lytic activity following secondary stimulation---does not invariably correlate with protection; instead, the better correlate of protection is the CTL precursor frequency. Recent observations indicate that certain effector functions are active in memory CTL and do not require prolonged stimulation. We suggest that these early effector functions of CTL, immediately following infection, are critical in controlling virus dissemination and in determining the outcome of the infection. Finally, we show that improved performance of the ubiquitinated minigenes most probably requires polyubiquitination of the fusion protein, suggesting that the enhancement results from more effective delivery of the minigene to the proteasome.


* Corresponding author. Mailing address: Dept. of Neuropharmacology, CVN-9, The Scripps Research Institute, 10550 N. Torrey Pines Rd., La Jolla, CA 92037. Phone: (619) 784-7090. Fax: (619) 784-7380. E-mail: lwhitton{at}scripps.edu.

dagger Manuscript 11246-NP from The Scripps Research Institute.


J Virol, June 1998, p. 5174-5181, Vol. 72, No. 6
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Huebener, N., Fest, S., Strandsby, A., Michalsky, E., Preissner, R., Zeng, Y., Gaedicke, G., Lode, H. N. (2008). A rationally designed tyrosine hydroxylase DNA vaccine induces specific antineuroblastoma immunity. Molecular Cancer Therapeutics 7: 2241-2251 [Abstract] [Full Text]  
  • Botten, J., Whitton, J. L., Barrowman, P., Sidney, J., Whitmire, J. K., Alexander, J., Ting, J. P. C., Bui, H.-H., Sette, A., Buchmeier, M. J. (2007). HLA-A2-Restricted Protection against Lethal Lymphocytic Choriomeningitis. J. Virol. 81: 2307-2317 [Abstract] [Full Text]  
  • Fernandez-Borges, N., Brun, A., Whitton, J. L., Parra, B., Diaz-San Segundo, F., Salguero, F. J., Torres, J. M., Rodriguez, F. (2006). DNA Vaccination Can Break Immunological Tolerance to PrP in Wild-Type Mice and Attenuates Prion Disease after Intracerebral Challenge.. J. Virol. 80: 9970-9976 [Abstract] [Full Text]  
  • Nussbaum, A. K., Whitton, J. L. (2004). The Contraction Phase of Virus-Specific CD8+ T Cells Is Unaffected by a Pan-Caspase Inhibitor. J. Immunol. 173: 6611-6618 [Abstract] [Full Text]  
  • Alexander, J., Oseroff, C., Dahlberg, C., Qin, M., Ishioka, G., Beebe, M., Fikes, J., Newman, M., Chesnut, R. W., Morton, P. A., Fok, K., Appella, E., Sette, A. (2002). A Decaepitope Polypeptide Primes for Multiple CD8+ IFN-{gamma} and Th Lymphocyte Responses: Evaluation of Multiepitope Polypeptides as a Mode for Vaccine Delivery. J. Immunol. 168: 6189-6198 [Abstract] [Full Text]  
  • Rodriguez, F., Harkins, S., Slifka, M. K., Whitton, J. L. (2002). Immunodominance in Virus-Induced CD8+ T-Cell Responses Is Dramatically Modified by DNA Immunization and Is Regulated by Gamma Interferon. J. Virol. 76: 4251-4259 [Abstract] [Full Text]  
  • Ye, M., Morello, C. S., Spector, D. H. (2002). Strong CD8 T-Cell Responses following Coimmunization with Plasmids Expressing the Dominant pp89 and Subdominant M84 Antigens of Murine Cytomegalovirus Correlate with Long-Term Protection against Subsequent Viral Challenge. J. Virol. 76: 2100-2112 [Abstract] [Full Text]  
  • Cho, J. H., Youn, J. W., Sung, Y. C. (2001). Cross-Priming as a Predominant Mechanism for Inducing CD8+ T Cell Responses in Gene Gun DNA Immunization. J. Immunol. 167: 5549-5557 [Abstract] [Full Text]  
  • Rodriguez, F., Harkins, S., Redwine, J. M., de Pereda, J. M., Whitton, J. L. (2001). CD4+ T Cells Induced by a DNA Vaccine: Immunological Consequences of Epitope-Specific Lysosomal Targeting. J. Virol. 75: 10421-10430 [Abstract] [Full Text]  
  • Fujimura, A. E., Kinoshita, S. S., Pereira-Chioccola, V. L., Rodrigues, M. M. (2001). DNA Sequences Encoding CD4+ and CD8+ T-Cell Epitopes Are Important for Efficient Protective Immunity Induced by DNA Vaccination with a Trypanosoma cruzi Gene. Infect. Immun. 69: 5477-5486 [Abstract] [Full Text]  
  • Rodriguez, F., Slifka, M. K., Harkins, S., Whitton, J. L. (2001). Two Overlapping Subdominant Epitopes Identified by DNA Immunization Induce Protective CD8+ T-Cell Populations with Differing Cytolytic Activities. J. Virol. 75: 7399-7409 [Abstract] [Full Text]  
  • Velders, M. P., Weijzen, S., Eiben, G. L., Elmishad, A. G., Kloetzel, P.-M., Higgins, T., Ciccarelli, R. B., Evans, M., Man, S., Smith, L., Kast, W. M. (2001). Defined Flanking Spacers and Enhanced Proteolysis Is Essential for Eradication of Established Tumors by an Epitope String DNA Vaccine. J. Immunol. 166: 5366-5373 [Abstract] [Full Text]  
  • Hassett, D. E., Slifka, M. K., Zhang, J., Whitton, J. L. (2000). Direct Ex Vivo Kinetic and Phenotypic Analyses of CD8+ T-Cell Responses Induced by DNA Immunization. J. Virol. 74: 8286-8291 [Abstract] [Full Text]  
  • Morello, C. S., Cranmer, L. D., Spector, D. H. (2000). Suppression of Murine Cytomegalovirus (MCMV) Replication with a DNA Vaccine Encoding MCMV M84 (a Homolog of Human Cytomegalovirus pp65). J. Virol. 74: 3696-3708 [Abstract] [Full Text]  
  • Sevilla, N., Homann, D., von Herrath, M., Rodriguez, F., Harkins, S., Whitton, J. L., Oldstone, M. B. A. (2000). Virus-Induced Diabetes in a Transgenic Model: Role of Cross-Reacting Viruses and Quantitation of Effector T Cells Needed To Cause Disease. J. Virol. 74: 3284-3292 [Abstract] [Full Text]  
  • Hassett, D. E., Zhang, J., Slifka, M., Whitton, J. L. (2000). Immune Responses following Neonatal DNA Vaccination Are Long-Lived, Abundant, and Qualitatively Similar to Those Induced by Conventional Immunization. J. Virol. 74: 2620-2627 [Abstract] [Full Text]  
  • Chen, C.-H., Wang, T.-L., Hung, C.-F., Yang, Y., Young, R. A., Pardoll, D. M., Wu, T-C. (2000). Enhancement of DNA Vaccine Potency by Linkage of Antigen Gene to an HSP70 Gene. Cancer Res. 60: 1035-1042 [Abstract] [Full Text]  
  • Zaia, J. A., Sissons, J.G. P., Riddell, S., Diamond, D. J., Wills, M.R., Carmichael, A.J., Weekes, M.P., Gandhi, M., La Rosa, C., Villacres, M., Lacey, S., Markel, S., Sun, J. (2000). Status of Cytomegalovirus Prevention and Treatment in 2000. ASH Education Book 2000: 339-355 [Abstract] [Full Text]  
  • Wherry, E. J., Puorro, K. A., Porgador, A., Eisenlohr, L. C. (1999). The Induction of Virus-Specific CTL as a Function of Increasing Epitope Expression: Responses Rise Steadily Until Excessively High Levels of Epitope Are Attained. J. Immunol. 163: 3735-3745 [Abstract] [Full Text]  
  • Fu, T.-M., Guan, L., Friedman, A., Schofield, T. L., Ulmer, J. B., Liu, M. A., Donnelly, J. J. (1999). Dose Dependence of CTL Precursor Frequency Induced by a DNA Vaccine and Correlation with Protective Immunity Against Influenza Virus Challenge. J. Immunol. 162: 4163-4170 [Abstract] [Full Text]  
  • Blaney, J. E. Jr., Nobusawa, E., Brehm, M. A., Bonneau, R. H., Mylin, L. M., Fu, T.-M., Kawaoka, Y., Tevethia, S. S. (1998). Immunization with a Single Major Histocompatibility Complex Class I-Restricted Cytotoxic T-Lymphocyte Recognition Epitope of Herpes Simplex Virus Type 2 Confers Protective Immunity. J. Virol. 72: 9567-9574 [Abstract] [Full Text]